John Virostko
Last active: 1/20/2015


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Detection of breast cancer microcalcification using (99m)Tc-MDP SPECT or Osteosense 750EX FMT imaging. Felix DD, Gore JC, Yankeelov TE, Peterson TE, Barnes S, Whisenant J, Weis J, Shoukouhi S, Virostko J, Nickels M, McIntyre JO, Sanders M, Abramson V, Tantawy MN (2015) Nucl Med Biol 42(3): 269-73
    › Primary publication · 25533764 (PubMed) · PMC4889014 (PubMed Central)
  2. Reply to "Assessment of MRI issues at 7 T". Dula AN, Virostko J, Shellock FG (2014) AJR Am J Roentgenol 203(5): W561
    › Primary publication · 25341180 (PubMed)
  3. Non-invasive bioluminescence imaging of β-cell function in obese-hyperglycemic [ob/ob] mice. Patel M, Gleason A, O'Malley S, Connolly B, Suresch D, Virostko J, Phillips N, Lin SA, Chen TB, Klimas M, Hargreaves RJ, Sur C, Williams DL, Powers AC, Bednar B (2014) PLoS One 9(9): e106693
    › Primary publication · 25198535 (PubMed) · PMC4157804 (PubMed Central)
  4. Differentiation between temporary and real non-clearability of biotinylated IgG antibody by avidin in mice. Dou S, Virostko J, Rusckowski M, Greiner DL, Powers AC, Liu G (2014) Front Pharmacol : 172
    › Primary publication · 25104938 (PubMed) · PMC4109569 (PubMed Central)
  5. Assessment of MRI issues at 7 T for 28 implants and other objects. Dula AN, Virostko J, Shellock FG (2014) AJR Am J Roentgenol 202(2): 401-5
    › Primary publication · 24450683 (PubMed)
  6. SPARCL1 suppresses metastasis in prostate cancer. Xiang Y, Qiu Q, Jiang M, Jin R, Lehmann BD, Strand DW, Jovanovic B, DeGraff DJ, Zheng Y, Yousif DA, Simmons CQ, Case TC, Yi J, Cates JM, Virostko J, He X, Jin X, Hayward SW, Matusik RJ, George AL, Yi Y (2013) Mol Oncol 7(6): 1019-30
    › Primary publication · 23916135 (PubMed) · PMC3838491 (PubMed Central)
  7. A novel reporter system for molecular imaging and high-throughput screening of anticancer drugs. Xie J, Wang C, Virostko J, Manning HC, Pham W, Bauer J, Gore JC (2013) Chembiochem 14(12): 1494-503
    › Primary publication · 23881799 (PubMed) · PMC3819221 (PubMed Central)
  8. Bioluminescence imaging reveals dynamics of beta cell loss in the non-obese diabetic (NOD) mouse model. Virostko J, Radhika A, Poffenberger G, Dula AN, Moore DJ, Powers AC (2013) PLoS One 8(3): e57784
    › Primary publication · 23483929 (PubMed) · PMC3590285 (PubMed Central)
  9. Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands. Virostko J, Henske J, Vinet L, Lamprianou S, Dai C, Radhika A, Baldwin RM, Ansari MS, Hefti F, Skovronsky D, Kung HF, Herrera PL, Peterson TE, Meda P, Powers AC (2011) Proc Natl Acad Sci U S A 108(51): 20719-24
    › Primary publication · 22143775 (PubMed) · PMC3251115 (PubMed Central)
  10. Magnetic nanoparticles for imaging dendritic cells. Kobukai S, Baheza R, Cobb JG, Virostko J, Xie J, Gillman A, Koktysh D, Kerns D, Does M, Gore JC, Pham W (2010) Magn Reson Med 63(5): 1383-90
    › Primary publication · 20432309 (PubMed) · PMC4888962 (PubMed Central)
  11. Validation of bioluminescent imaging techniques. Virostko J, Jansen ED (2009) Methods Mol Biol : 15-23
    › Primary publication · 19685296 (PubMed)
  12. Bioluminescence imaging in mouse models quantifies beta cell mass in the pancreas and after islet transplantation. Virostko J, Radhika A, Poffenberger G, Chen Z, Brissova M, Gilchrist J, Coleman B, Gannon M, Jansen ED, Powers AC (2010) Mol Imaging Biol 12(1): 42-53
    › Primary publication · 19548035 (PubMed) · PMC3822006 (PubMed Central)
  13. A molecular imaging paradigm to rapidly profile response to angiogenesis-directed therapy in small animals. Virostko J, Xie J, Hallahan DE, Arteaga CL, Gore JC, Manning HC (2009) Mol Imaging Biol 11(3): 204-12
    › Primary publication · 19130143 (PubMed) · PMC2677126 (PubMed Central)
  14. Molecular imaging of the pancreas in small animal models. Virostko J, Powers AC (2009) Gastroenterology 136(2): 407-9
    › Primary publication · 19105957 (PubMed) · PMC3740180 (PubMed Central)
  15. Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer. Manning HC, Merchant NB, Foutch AC, Virostko JM, Wyatt SK, Shah C, McKinley ET, Xie J, Mutic NJ, Washington MK, LaFleur B, Tantawy MN, Peterson TE, Ansari MS, Baldwin RM, Rothenberg ML, Bornhop DJ, Gore JC, Coffey RJ (2008) Clin Cancer Res 14(22): 7413-22
    › Primary publication · 19010858 (PubMed) · PMC2657180 (PubMed Central)
  16. Validation of luminescent source reconstruction using single-view spectrally resolved bioluminescence images. Virostko J, Powers AC, Jansen ED (2007) Appl Opt 46(13): 2540-7
    › Primary publication · 17429468 (PubMed)
  17. Effect of optical tissue clearing on spatial resolution and sensitivity of bioluminescence imaging. Jansen ED, Pickett PM, Mackanos MA, Virostko J (2006) J Biomed Opt 11(4): 041119
    › Primary publication · 16965147 (PubMed)
  18. Current status of imaging pancreatic islets. Virostko J, Jansen ED, Powers AC (2006) Curr Diab Rep 6(4): 328-32
    › Primary publication · 16879787 (PubMed)
  19. Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging. Fowler M, Virostko J, Chen Z, Poffenberger G, Radhika A, Brissova M, Shiota M, Nicholson WE, Shi Y, Hirshberg B, Harlan DM, Jansen ED, Powers AC (2005) Transplantation 79(7): 768-76
    › Primary publication · 15818318 (PubMed)
  20. Factors influencing quantification of in vivo bioluminescence imaging: application to assessment of pancreatic islet transplants. Virostko J, Chen Z, Fowler M, Poffenberger G, Powers AC, Jansen ED (2004) Mol Imaging 3(4): 333-42
    › Primary publication · 15802050 (PubMed)